Longevity
Factlen Research
Landmark $38M Trial Tests Rapamycin, GLP-1, and SGLT2 Inhibitors as First Longevity Drugs in Healthy Adults
4 sources · 12d ago
Factlen Research
The Evidence Pack: How Reprogrammed CAR-T Cells Are Eliminating 'Zombie Cells' to Reverse Aging in Mice
5 sources · 17d ago
Factlen Deep Dive
First Patient Achieves Sustained Insulin Independence Following Autologous Stem Cell-Derived Islet Transplant
3 sources · 17d ago
More in Longevity
Factlen ExplainerAlzheimer's Disease
The Evidence Pack: How the FDA-Approved Antibody Donanemab is Rewriting Alzheimer's Treatment
Clinical Researchers 47%Patient Advocacy Groups 35%Healthcare Economists 18%
6 sources · 18d ago
Factlen Deep DiveMetabolic Aging
Landmark Study Identifies Unique Bile Acid and Steroid 'Fingerprint' in Centenarians Linked to Exceptional Longevity
Microbiome Researchers 39%Translational Gerontologists 39%Metabolic Biologists 22%
4 sources · 19d ago